+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
From
Smart Inhalers: Global Markets - Product Thumbnail Image

Smart Inhalers: Global Markets

  • Report
  • September 2020
  • 107 Pages
From
From
Global Smart Inhaler Technology Market 2020-2024 - Product Thumbnail Image

Global Smart Inhaler Technology Market 2020-2024

  • Report
  • November 2020
  • 120 pages
From
From
From
Inhalable Drugs Market 2020-2026 - Product Thumbnail Image

Inhalable Drugs Market 2020-2026

  • Report
  • February 2020
From
From
From
From
Loading Indicator
adroll